TransMedics Group Inc

TMDX

Company Profile

  • Business description

    TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

  • Contact

    200 Minuteman Road
    AndoverMA01810
    USA

    T: +1 978 552-0900

    https://www.transmedics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    898

Stocks News & Analysis

stocks

Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity

Ongoing rate hikes have investors spooked.
stocks

ASX dividend champions: Stocks, ETFs and LICs

Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.
stocks

SpaceX’s IPO filing: Big spending, big losses

The first public financials from Elon Musk’s company highlight Starlink’s revenue power and increased spending on AI.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,840.809.50-0.11%
CAC 408,086.0031.42-0.39%
DAX 4024,606.77130.47-0.53%
Dow JONES (US)50,353.77344.420.69%
FTSE 10010,443.4711.130.11%
HKSE25,386.52264.60-1.03%
NASDAQ26,315.5245.160.17%
Nikkei 22561,684.141,879.733.14%
NZX 50 Index12,878.07117.040.92%
S&P 5007,450.1317.160.23%
S&P/ASX 2008,621.706.30-0.07%
SSE Composite Index4,077.2884.91-2.04%

Market Movers